Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 11/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6988890 | 0.72 | BRD4 (0.53) | BRD4CHRNB2CHRNA4 | |
| SCHEMBL1028127 | 0.70 | BRD4 (0.44) | BRD4CHRNB2CHRNA4 | |
| SCHEMBL14431590 | 0.68 | BRD4 (0.50) | BRD4CHRNB2CHRNA4 | |
| SCHEMBL17307555 | 0.68 | BRD4 (0.38) | BRD4CHRNB2CHRNA4 | |
| SCHEMBL1033711 | 0.68 | BRD4 (0.50) | BRD4HTT | |
| SCHEMBL30007774 | 0.68 | BRD4 (0.50) | BRD4HTT | |
| SCHEMBL1027255 | 0.68 | BRD4 (0.41) | BRD4CHRNB2CHRNA4MAPTALOX15 | |
| SCHEMBL28847477 | 0.68 | ALDH1A1 (0.43) | HTTMAPTALOX15 | |
| SCHEMBL14759859 | 0.66 | P2RX7 (0.48) | P2RX7 | |
| SCHEMBL8418298 | 0.66 | BRD4 (0.44) | BRD4CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215856-B | Preparation method of PPAR delta agonist Funadepad and intermediate thereof | 沈阳药科大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-115215856-A | Preparation method of PPAR delta agonist finadepa and intermediate thereof | 沈阳药科大学 | 2022-10-21 | — | — | CN | disclosed |